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Abstract
 
The P2X
 
1
 
 receptor is a fast ATP-gated cation channel expressed in blood platelets, where its
role has been difficult to assess due to its rapid desensitization and the lack of pharmacological
tools. In this paper, we have used P2X
 
1
 
 
 
/
 
 
 
 and wild-type mouse platelets, treated with apyrase
to prevent desensitization, to demonstrate the function of P2X
 
1
 
 in the response to thrombo-
genic stimuli. In vitro, the collagen-induced aggregation and secretion of P2X
 
1
 
-deficient
platelets was decreased, as was adhesion and thrombus growth on a collagen-coated surface,
particularly when the wall shear rate was elevated. In vivo, the functional role of P2X
 
1
 
 could
be demonstrated using two models of platelet-dependent thrombotic occlusion of small arteries,
in which blood flow is characterized by a high shear rate. The mortality of P2X
 
1
 
 
 
/
 
 
 
 mice in a
model of systemic thromboembolism was reduced and the size of mural thrombi formed after a
laser-induced vessel wall injury was decreased as compared with normal mice, whereas the time
for complete thrombus removal was shortened. Overall, the P2X
 
1
 
 receptor appears to contribute
to the formation of platelet thrombi, particularly in arteries in which shear forces are high.
Key words: platelet • P2 receptors • arterial thrombosis • knockout mice • shear forces
 
Introduction
 
Platelet activation, recruitment, and aggregation are crucial
events in the maintenance of hemostasis and in the devel-
opment of an arterial thrombus. ADP and ATP are released
from platelets stimulated by agonists such as thrombin or
collagen, and the released ADP plays a central part in these
processes. Purine nucleotides mediate signaling in platelets
through three different P2 receptors (1), the ADP-sensitive
G protein–coupled P2Y
 
1
 
 receptor (2, 3), the P2Y
 
12
 
 recep-
tor (4, 5), and the ATP-sensitive ligand-gated P2X
 
1
 
 cation
channel (6, 7). The role of the P2X
 
1
 
 receptor in platelet
function has long been difficult to assess due to a lack of
potent and selective antagonists. In addition, one of the
main properties of this receptor is its rapid and lasting de-
sensitization (8). In fact, preparation of platelet-rich plasma
or washed platelets for in vitro studies induces leakage of
nucleotides susceptible to desensitize platelet responses to
ADP (9). Therefore, apyrase (ATP-diphosphohydrolase
E.C.3.6.1.5.), an ATP- and ADP-removing enzyme, is
commonly used to prevent this drawback (9). However, as
described previously (10), it is necessary to add higher con-
centrations of apyrase at each step of platelet handling to
prevent desensitization of the platelet P2X
 
1
 
 receptor. Un-
der these conditions, 
 
 
 
,
 
 
 
-methylene-ATP (
 
  
 
MeATP), a
nonmetabolizable P2X
 
1
 
 agonist, induces a rapid calcium
influx and transient shape change of human platelets (10).
Oury et al. have further suggested that this receptor could be
involved in aggregation of human platelets induced by col-
lagen (11). However, the in vivo role of the P2X
 
1
 
 receptor
in hemostasis and/or thrombosis has not yet been elucidated.
P2X
 
1
 
-deficient mice (P2X
 
1
 
 
 
/
 
 
 
 mice) have been gener-
ated and found to exhibit male infertility, indicating that
this receptor is essential for male reproductive function
through its role in vas deferens contraction in response to
sympathetic nerve stimulation (12). We have used this
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mouse strain to assess the involvement of the P2X
 
1
 
 recep-
tor in hemostasis and thrombosis.
 
Materials and Methods
 
Mouse Strains.
 
P2X
 
1
 
 
 
/
 
 
 
 mice were generated as described
previously (12); these mice of 129Ola-MF1 genetic background
were backcrossed with the C57BL/6 mouse strain for nine gen-
erations. Hence, the wild-type (WT) and P2X
 
1
 
 
 
/
 
 
 
 mice used in
this work were of pure C57BL/6 genetic background. Genotyp-
ing was performed on mouse tail DNA by a PCR amplification
method (12). Complete blood cell counts were determined as de-
scribed previously (2).
 
Bleeding Time.
 
The bleeding time was measured by severing
3 mm from the distal end of the tail of 8-wk-old WT or P2X
 
1
 
 
 
/
 
 
 
male mice. If no cessation of blood flow occurred after 30 min,
the tail was cauterized and 
 
 
 
1,800 s was recorded as the bleed-
ing time.
 
Washed Platelet Studies.
 
Washed platelet suspension was pre-
pared as described previously (13) except that 1.8 U/ml apyrase
was added at each step of the washing procedure and in the final
resuspending buffer to prevent desensitization of the P2X
 
1
 
 recep-
tor. Aggregation, secretion, a platelet-loading procedure with
fura-2/AM, and intracellular calcium measurements were per-
formed as described previously (13).
 
In Vitro Model of Platelet Interaction with Immobilized Collagen in a
Flow System.
 
The interaction of platelets with immobilized col-
lagen type I fibrils was studied using an established method (14).
Heparin-anticoagulated whole blood, drawn from the retro-
orbital vein of mice and containing 1.5 U/ml apyrase, was labeled
with 10 
 
 
 
M of the fluorescent dye mepacrine before perfusion at
various shear rates through a flow chamber, in which 0.1 mg/ml
collagen-coated coverslips formed the lower surface of the flow
chamber. The flow chamber, mounted on an epifluorescence mi-
croscope (Axiovert model 135M; Carl Zeiss MicroImaging,
Inc.), allowed direct visualization of the platelet adhesion and ag-
gregation process, which was recorded with a VCR (model
SVO-9500MD; Sony). Thrombus volume was measured in real
time by confocal videomicroscopy (model LSM 410; Carl Zeiss
MicroImaging, Inc.). Analysis of surface coverage was performed
off-line on single frames obtained from the videotape recording
(acquisition rate: 30 frames/s) and processed with a software
package (Metamorph, Version 5; Universal Imaging Corp.).
 
In Vivo Models of Thrombosis.
 
A model of acute systemic vas-
cular occlusion caused by intravascular platelet aggregation in-
duced by infusion of a mixture of collagen and adrenaline was
performed as described previously (2, 15). Platelet-independent
pulmonary embolism was induced by i.v. injection of a 12.5%
suspension of hardened rat RBCs (16). Localized thrombosis of
mesenteric arterioles induced by laser injury was performed with
male mice weighing 15 g. The mesentery of anesthetized mice
was exteriorized and an arteriole with a diameter of 65–100 
 
 
 
m
was observed under an inverted microscope (model DMIRB;
Leica) coupled to a video camera (DAGE MTI). Localized in-
jury of the luminal surface of the vessel was induced using a 440-
nm pulsed nitrogen dye laser applied through the microscope
objective with a Micropoint laser system (Photonics Instru-
ments; reference 17). The thrombus development, visualized in
real time, triggered in this model mainly involves platelet inter-
actions (18). Six to eight arterioles were targeted over a period of
30 min, only one injury being made on each vessel. The manip-
ulator was unaware of the mouse genotype while performing
these experiments.
 
Results
 
Hematological Characterization of P2X
 
1
 
 
 
/
 
 
 
 Mice.
 
The he-
matological profile of P2X
 
1
 
 
 
/
 
 
 
 mice revealed normal
erythrocyte and leukocyte counts and normal hemoglobin
and hematocrit. The distribution of leukocyte cell types
was also similar between the two genotypes. Platelet
counts were indistinguishable between WT and P2X
 
1
 
 
 
/
 
 
 
mice (1,230 
 
 
 
 41 
 
 
 
 10
 
3
 
 vs. 1,226 
 
 
 
 52 
 
 
 
 10
 
3
 
 platelets/
 
 
 
l, 
 
n 
 
  
 
15; unpublished data). No spontaneous bleeding
was observed in P2X
 
1
 
 
 
/
 
 
 
 mice and the bleeding time as
measured by tail transsection was normal in most of the
P2X
 
1
 
 
 
/
 
 
 
 mice as compared with WT mice (Fig. 1). This
result suggests that lack of the P2X
 
1
 
 receptor has a modest
impact, if any, on primary hemostasis in mice. Clot retrac-
tion evaluated on whole blood was found similar between
the two genotypes.
 
P2X
 
1
 
 
 
/
 
 
 
 Mouse Platelets Exhibit Decreased Aggregation in
Response to Collagen.
 
The presence of a functional P2X
 
1
 
receptor was examined by measuring variations in intracel-
lular calcium ([Ca
 
2
 
 
 
]
 
i
 
) in washed platelets. In the presence
of a high concentration of apyrase (1.8 U/ml) at each step
of platelet handling to maintain a functional P2X
 
1
 
 receptor,
 
  
 
MeATP (0.1–100 
 
 
 
M) induced a transient [Ca
 
2
 
 
 
]
 
i
 
 in-
crease in WT but not in P2X
 
1
 
 
 
/
 
 
 
 platelets. The calcium
rise induced by 100 
 
 
 
M 
 
  
 
MeATP peaked at 91 
 
 
 
 4 nM
(
 
n 
 
  
 
4) above basal levels and returned to these levels after
50 s (Fig. 2 A). It was abolished in the absence of external
calcium, indicating that the increase was due to calcium
entry from the external medium.
Under these conditions, at a low collagen concentration
(0.5 
 
 
 
g/ml), aggregation of P2X
 
1
 
 
 
/
 
 
 
 platelets was reduced
as compared with the WT (Fig. 2 B). This diminished re-
sponse was still visible at somewhat higher collagen con-
centrations (1 and 1.25 
 
 
 
g/ml), whereas at concentrations
exceeding 2.5 
 
 
 
g/ml, WT and P2X
 
1
 
 
 
/
 
 
 
 platelets displayed
comparable aggregation. Similar results were obtained by
desensitizing the P2X
 
1
 
 receptor of WT mouse platelets
Figure 1. Tail bleeding time
of WT and P2X1
    male mice.
The bleeding time was normal in
most of the P2X1
 /  mice (n  
34, median 107 s) as compared
with WT mice (n   32, median
85 s).T
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with 
 
  
 
MeATP (unpublished data). The alteration of col-
lagen-induced platelet activation was not due to a differ-
ence in collagen receptor or other major platelet glycopro-
tein density as flow cytometric analyses indicated normal
amounts of 
 
 
 
2
 
 
 
1 integrin, GPIb–IX, or GPIIbIIIa com-
plexes on WT and P2X1
 /  platelets (unpublished data).
Moreover, this decreased reactivity of P2X1
 /  platelets
was limited to collagen, because no difference could be ob-
served as compared with the WT when aggregation was
triggered by ADP (100  M, inducing only a weak response
in the presence of the high concentration of apyrase) or by
low concentrations of agonists such as the 2  M throm-
boxane A2 analogue U46619 or 0.05 U/ml thrombin,
both of which induce release of nucleotides from the dense
granules (unpublished data).
Parallel measurements of the release reaction triggered
by collagen in platelets loaded with [3H]serotonin ([3H]5-
HT) demonstrated a decreased [3H]5-HT release in P2X1
 / 
platelets as compared with WT, consistent with a contri-
bution of P2X1 to this platelet response (Fig. 2 B). In con-
trast, 1 U/ml thrombin elicited similar [3H]5-HT release in
the two genotypes. Altogether, these in vitro studies indi-
cated only a minor role of the P2X1 receptor in platelet ag-
gregation and secretion in response to low concentrations
of collagen.
A Role of the P2X1 Receptor in Thrombus Growth on Immo-
bilized Collagen at High Shear Rates. Platelet aggregation in
response to collagen in an aggregometer cuvette may not
represent a reflection of events as they occur in vivo, where
platelets establish contact only with insoluble collagen in
extracellular matrices under flow. Therefore, we studied
platelet thrombus formation on a collagen-coated surface,
under flow conditions generating wall shear rates between
800 and 6,000 s 1 to cover the range encountered in larger
arteries as well as arterioles (19). At a relatively low shear
rate (800 s 1), there was no difference in surface coverage
by thrombi between WT and P2X1
 /  blood (P   0.088,
n   3; Fig. 3 A). At a higher shear rate (2,000 s 1), surface
coverage by thrombi tended to be lowered in P2X1
 / 
blood as compared with WT, but the difference failed to
reach statistical significance (P   0.067, n   9). In contrast,
at the highest shear rate tested (6,000 s 1), thrombus forma-
tion was significantly decreased in the P2X1
 /  blood as
compared with WT (*, P   0.032, n   15; Fig. 3 A). The
distribution of adherent and aggregated platelets was not
homogeneous in the P2X1
 /  blood, and the platelet
Figure 2. In vitro evaluation
of platelet P2X1 receptor func-
tion. (A) [Ca2 ]i measurements
in washed platelet suspensions.
In the presence of 1.8 U/ml apy-
rase, 100  M    MeATP elic-
ited a [Ca2 ]i rise in WT but not
in P2X1
 /  platelets, which was
abolished in the absence of ex-
ternal calcium (0.2 mM EGTA).
(B) Aggregation of WT (black
lines) and P2X1
 /  (gray lines)
platelets in response to various
concentrations of collagen.
P2X1
 /  platelets showed a di-
minished response to collagen as
compared with WT platelets.
The percentage [3H]serotonin
secretion, as indicated in brack-
ets, was reduced in P2X1
 / 
platelets as compared with WT
platelets (values are from two in-
dependent experiments). Trac-
ings are from one experiment
representative of five independent
experiments with identical results.T
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thrombi that formed in the absence of P2X1 function grew
to a normal size in the areas where they developed (Fig. 3
B). For this reason, the direct measurements of thrombus
volume, which were performed on predetermined areas
before the beginning of perfusion, showed a considerable
variability, and the difference observed between normal
and P2X1
 /  blood, although clear, failed to reach statisti-
cal significance (P   0.36, n   6). For technical reasons,
thrombus volume could only be measured on surfaces that
correspond to 1/16 of the areas shown in Fig. 3 B; thus,
with the P2X1
 /  blood, the values obtained could range
from normal to markedly decreased depending on the ran-
domly selected position on the surface.
P2X1
 /  Mice Are Resistant to Thrombosis In Vivo. The re-
sults of in vitro experiments showed that platelet interaction
with a collagen-coated surface was defective in P2X1
 / 
blood perfused at high shear rates. However, the differ-
ence between WT and P2X1
 /  platelets could have been
underestimated in our in vitro studies, due to incomplete
recovery by added apyrase of desensitized receptors in WT
platelets and/or to an inappropriate environment even un-
der flow conditions. For this reason, to avoid platelet han-
dling and desensitization of the P2X1 receptor, we chose
to evaluate further the role of this receptor in vivo using
two models of thrombosis in which platelet activation is
critical. The first was a model of acute vascular occlusion
due to intravascular platelet aggregation induced by infu-
sion of a mixture of collagen and adrenaline into the jugu-
lar vein (2, 15). This led to death in 14 of 16 WT mice
within 6 min, which was due to extensive obstruction of
the lung microcirculation with occlusive thrombi (Fig. 4
A). In contrast, among 15 P2X1
 /  mice, 6 died within 6
min and 1 after 13 min, whereas the 8 others survived the
challenge for the 90-min observation period. The effect of
genotype on survival was significant by log-rank test (P  
0.0026), and the percentage of P2X1
 /  mice that sur-
vived for 90 min was significantly greater than the per-
centage of WT mice that survived (P   0.0151,  2 test).
Histological analysis of the lungs of P2X1
 /  mice that re-
covered showed that only a few vessels were obstructed
and that the thrombi were rarely occlusive (Fig. 4 A).
Thus, P2X1
 /  mice were resistant to the fatal occlusion
of the microvasculature, indicating a role of the P2X1 re-
ceptor in this model. To assess whether vascular P2X1 re-
ceptors, which have been shown to play a role in vasocon-
striction of arteries (20), contributed to the observed
phenotype, mice were tested in a model of mechanical
pulmonary embolism, induced by i.v. injection of hard-
ened rat RBCs, that is independent of platelet activation
(16). Only 18% of WT mice were still alive 45 min after
the infusion, and there was no significant difference in
mortality for P2X1
 /  mice (log-rank test NS, P  
0.3909; Fig. 4 B). In contrast, there was a 100% survival
rate after vasodilation of WT mice with the calcium chan-
nel antagonist nifedipine (100 mg/kg), (significantly differ-
ent from WT or P2X1
 /  mice, P   0.0003 and P  
0.0076 by log-rank test, respectively). This implies that
any vasodilation due to the deficiency of vascular P2X1 re-
ceptor does not contribute significantly to the resistance of
P2X1
 /  mice to fatal thromboembolism.
Other experiments were performed in a model of local-
ized thrombosis in mesenteric arterioles triggered by laser-
induced vessel wall injury. The time course of thrombus
formation in WT mice showed that platelets accumulated
rapidly, a maximum height of 13.7   1.7  m (n   15 ves-
sels in four different mice) being reached within 30 s of in-
jury and diminishing until complete removal of the throm-
bus after 120 s (Fig. 5). The size of the thrombus in P2X1
 / 
mice was markedly reduced, reaching only 5.1   1.1  m
(n   16 vessels in four different mice; P   0.0005, Wil-
coxon signed rank test) with complete removal after 70 s.
Thus, P2X1
 /  mice failed to develop an adequate throm-
botic mass and the thrombi that formed were easily dis-
persed. Vasoconstriction was not reduced as measurement
of vessel diameters before and after laser-induced injury
(percentage of vasoconstriction) was found similar between
WT (36   7%, n   15) and P2X1
 /  (29   5%, n   16)
mice (P   0.64, Mann-Whitney test). These findings indi-
cate that the P2X1 receptor may contribute to modulate
Figure 3. Role of the platelet P2X1 receptor in thrombus growth on a
collagen-coated surface at high shear rates. (A) Surface coverage by plate-
let thrombi formed on a surface coated with 0.1 mg/ml type I collagen
fibrils. Blood was perfused for 90–240 s at the indicated shear rates. Sur-
face coverage by thrombi was significantly decreased in P2X1
 /  blood
only at the shear rate of 6,000 s 1 (*, P   0.032, n   15). (B) Volume of
thrombi formed on a 0.1-mg/ml collagen-coated surface after perfusion
for 150 s at 6,000 s 1 wall shear rate with either WT or P2X1
 /  blood
(P   0.36, n   6). Two single frame images at low magnification from a
real time recording of one such experiment are also shown. Thrombi ap-
peared as bright objects rendered fluorescent by the incorporation of me-
pacrine into platelet granules.T
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the formation and reversal of localized arteriolar thrombus
after laser-induced vessel injury.
Discussion
We report here that under optimal in vitro conditions,
the P2X1 receptor contributes to the response of platelets
exposed to collagen under flow conditions characterized by
elevated shear stress, and enhances thrombosis in injured
small arteries in vivo. Although the bleeding time was nor-
mal in most of the P2X1
 /  mice, indicating that lack of
the P2X1 receptor has a modest impact if any on primary
hemostasis in the microcirculation, this pattern was very
similar to what it had been observed with the P2Y1
 / 
mice (2) and in the GPVI /  mice, opening the “intrigu-
ing possibility that such target may be more relevant for
pathological thrombus formation and less essential for nor-
mal hemostasis” as pointed out by Kato et al. (21). This is
very different from mice with GPIIbIIIa or with P2Y12 de-
ficiency, for example, where the bleeding time is dramati-
cally prolonged (5, 22). P2X1
 /  mice displayed resistance
to a model of acute thromboembolism that normally leads
to massive occlusion of the pulmonary microvessels with
platelet aggregates. In a model of mechanical embolism, the
vascular P2X1 receptor did not appear to contribute signifi-
cantly to the phenotype, whereas survival of the P2X1
 / 
mice was slightly increased as compared with that of WT
mice. Moreover, in a model of localized arterial thrombosis
Figure 4. Resistance of P2X1
    mice to acute systemic
intravascular thromboembolism. (A) Representative histo-
logical sections of lungs of WT or P2X1
 /  mice challenged
with collagen and adrenaline (top). Frequent occurrence of
occlusive intravascular thrombi in lungs of WT mice (left,
arrows) compared with unobstructed vessels in lungs of
P2X1
 /  mice (right, arrows). Time from 0.3 mg/kg col-
lagen and 60  g/kg adrenaline injection to death of mice
(bottom). Results are expressed as the percentage of mice
alive as a function of time. The effect of genotype on sur-
vival was significant by log-rank test (P   0.0026). (B)
Mechanical thromboembolism induced by i.v. infusion of hardened rat RBCs. 100 mg/kg nifedipine was administered per os 3 h before i.v. challenge
with hardened RBCs. The effect of nifedipine treatment on survival of WT mice was significant by log-rank test ( P   0.0003) as was the survival of
nifedipine-treated WT mice as compared with P2X1
 /  mice (P   0.0076). In contrast, the survival of WT mice was not significantly different as com-
pared with that of P2X1
 /  mice (NS, P   0.3909).
Figure 5. A key role of the platelet P2X1 receptor in arterial thrombo-
sis. Representative photographs of the thrombus formed after laser-
induced injury of the wall of mesenteric arterioles in WT and P2X1
 / 
mice (top). Arterioles with a diameter of 65–100  m were targets for in-
jury. Kinetics of thrombus formation in mesenteric arterioles of WT
(closed squares) and P2X1
 /  (closed triangles) mice (top). Values are the
mean thrombus height ( SEM) at each time point in four WT mice (n  
15 vessels) and four P2X1
 /  mice (n   16 vessels), and time 0 corre-
sponds to the time of injury.T
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of the mesenteric arterioles triggered by laser-induced ves-
sel wall injury, the extent of thrombus development was
reduced in P2X1
 /  mice, pointing to a role of the P2X1
receptor in thrombus formation and growth at sites of en-
dothelial damage of vessels in which blood flow generates
high shear forces.
The fact that the effect of P2X1 was more evident in in
vivo studies could be ascribed to the persistence of some
desensitization of the receptor in WT platelets, despite our
attempts to rescue P2X1 function with high concentrations
of apyrase. In vivo, P2X1 desensitization is prevented, be-
cause platelets circulate in the vicinity of endothelial cells,
which maintain a nonthrombogenic surface by expressing
in particular the ectoenzyme CD39 (23). CD39 converts
circulating extracellular nucleotides, such as ATP and
ADP, into AMP and, thus, protects the platelet P2 recep-
tors from desensitization as highlighted by a paper on mice
deficient in CD39, which are resistant to thrombosis as a
result of desensitization of the P2Y1 receptor (24). Further-
more, AMP is further metabolized by the endothelial 5 -
nucleotidase to adenosine, another powerful inhibitor of
platelet activation. In addition, prostacyclin (PGI2) and ni-
tric oxide (NO), produced by endothelial cells, contribute
to the thromboregulatory properties of the endothelium by
inducing vasodilation and inhibition of platelet activation,
especially when the cells are exposed to high shear condi-
tions (23). Interestingly, the contribution of the P2X1 re-
ceptor was found to be more important when levels of
cAMP or cGMP were elevated in platelets, as would be the
case in vivo in platelets exposed to the endothelial products
PGI2 and NO (25). Thus, the mechanisms displayed by en-
dothelial cells to inhibit the interactions of platelets with
the vessel wall are also involved in maintaining high and
fast responsiveness of platelets. Rapid calcium entry
through the P2X1 cation channel (within 10 ms) and the
subsequent calcium response triggered by stimulation of the
P2Y1 receptor (200 ms) displayed marked synergy, thereby
accelerating and amplifying the overall peak increase in
[Ca2 ]i (25, 26). Hence, it can be hypothesized that at sites
of injury in vessels subjected to high shear conditions, re-
lease of ATP, stored with ADP in the dense granules, in-
duces a rapid calcium influx through activation of the P2X1
receptor, which will synergize with the slower calcium in-
crease triggered by ADP-induced activation of the P2Y1
receptor, leading to platelet aggregation and thrombus for-
mation. Therefore, the more rapid response when the
P2X1 receptor is functional should be of importance in de-
termining whether or not platelets are activated quickly
enough to form a platelet plug in vivo. The results of our
in vitro studies on collagen-coated surfaces clearly indicate
that the P2X1 receptor may be required to initiate throm-
bus formation on surfaces exposed to rapidly flowing
blood. The functional defect of P2X1 is likely to result in
impaired platelet recruitment into a growing thrombus be-
cause the platelets that attach to the surface are not fully ac-
tivated. This may also cause some impairment of initial ad-
hesion, because irreversible platelet attachment to a reactive
substrate is also dependent on activation. Hence, the P2X1
receptor may contribute in a significant manner to the ini-
tiation of thrombosis at sites of stenosis in atherosclerotic
arteries, particularly in response to relatively mild vascular
insults (19).
In summary, besides the G protein–coupled ADP re-
ceptors, P2Y1 and P2Y12, known to be critically involved
in hemostasis and thrombosis, our results point to a role
of the P2X1 receptor in arterial thrombosis under high
shear conditions.
The authors would like to thank J.N. Mulvihill for reviewing the
manuscript and N. Lantz for histomorphological analysis. 
This work was supported by INSERM, Association de Recher-
che et de Développement en Médecine et Santé Publique, EFS-
Alsace, Fondation de France (no. 2002005149), the National Insti-
tutes of Health (HL-31950), and the Wellcome Trust.
Submitted: 29 January 2003
Revised: 12 June 2003
Accepted: 12 June 2003
References
1. Gachet, C. 2001. ADP receptors of platelets and their inhibi-
tion. Thromb. Haemost. 86:222–232.
2. Léon, C., B. Hechler, M. Freund, A. Eckly, C. Vial, P. Ohl-
mann, A. Dierich, M. LeMeur, J.P. Cazenave, and C. Ga-
chet. 1999. Defective platelet aggregation and increased resis-
tance to thrombosis in purinergic P2Y(1) receptor-null mice.
J. Clin. Invest. 104:1731–1737.
3. Fabre, J.E., M. Nguyen, A. Latour, J.A. Keifer, L.P. Audoly,
T.M. Coffman, and B.H. Koller. 1999. Decreased platelet
aggregation, increased bleeding time and resistance to throm-
boembolism in P2Y1-deficient mice. Nat. Med. 5:1199–
1202.
4. Hollopeter, G., H. Jantzen, D. Vincent, G. Li, L. England, V.
Ramakrishan, R. Yang, P. Nurden, A. Nurden, D. Julius,
and P. Conley. 2001. Identification of the platelet ADP re-
ceptor targeted by antithrombotic drugs. Nature. 409:202–
207.
5. Foster, C.J., D.M. Prosser, J.M. Agans, Y. Zhai, M.D. Smith,
J.E. Lachowicz, F.L. Zhang, E. Gustafson, F.J. Monsma, Jr.,
M.T. Wiekowski, et al. 2001. Molecular identification and
characterization of the platelet ADP receptor targeted by
thienopyridine antithrombotic drugs. J. Clin. Invest. 107:
1591–1598.
6. MacKenzie, A.B., M.P. Mahaut-Smith, and S.O. Sage. 1996.
Activation of receptor-operated cation channels via P2X1
not P2T purinoceptors in human platelets. J. Biol. Chem.
271:2879–2881.
7. Vial, C., B. Hechler, C. Léon, J.P. Cazenave, and C. Gachet.
1997. Presence of P2X1 purinoceptors in human platelets
and megakaryoblastic cell lines. Thromb. Haemost. 78:1500–
1504.
8. North, R.A. 2002. Molecular physiology of P2X receptors.
Physiol. Rev. 82:1013–1067.
9. Baurand, A., A. Eckly, N. Bari, C. Léon, B. Hechler, J.P.
Cazenave, and C. Gachet. 2000. Desensitization of the plate-
let aggregation response to ADP: differential down-regula-
tion of the P2Y1 and P2cyc receptors. Thromb. Haemost. 84:
484–491.
10. Rolf, M.G., C.A. Brearley, and M.P. Mahaut-Smith. 2001.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
667 Hechler et al. Brief Definitive Report
Platelet shape change evoked by selective activation of P2X1
purinoceptors with alpha,beta-methylene ATP. Thromb. Hae-
most. 85:303–308.
11. Oury, C., E. Toth-Zsamboki, C. Thys, J. Tytgat, J. Ver-
mylen, and M.F. Hoylaerts. 2001. The ATP-gated P2X1 ion
channel acts as a positive regulator of platelet responses to
collagen. Thromb. Haemost. 86:1264–1271.
12. Mulryan, K., D.P. Gitterman, C.J. Lewis, C. Vial, B.J.
Leckie, A.L. Cobb, J.E. Brown, E.C. Conley, G. Buell, C.A.
Pritchard, and R.J. Evans. 2000. Reduced vas deferens con-
traction and male infertility in mice lacking P2X1 receptors.
Nature. 403:86–89.
13. Ohlmann, P., A. Eckly, M. Freund, J.P. Cazenave, S. Offer-
manns, and C. Gachet. 2000. ADP induces partial platelet ag-
gregation without shape change and potentiates collagen-
induced aggregation in the absence of Galphaq. Blood. 96:
2134–2139.
14. Savage, B., F. Almus-Jacobs, and Z.M. Ruggeri. 1998. Spe-
cific synergy of multiple substrate-receptor interactions in
platelet thrombus formation under flow. Cell. 94:657–666.
15. DiMinno, G., and M.J. Silver. 1983. Mouse antithrombotic
assay: a simple method for the evaluation of antithrombotic
agents in vivo. Potentiation of antithrombotic activity by
ethyl alcohol. J. Pharmacol. Exp. Ther. 225:57–60.
16. Guarneri, L., A. Molinari, F. Casacci, E. Pacei, C. Cerletti,
and G. de Gaetano. 1988. A new model of pulmonary mi-
croembolism in the mouse. J. Pharmacol. Methods. 20:161–
167.
17. Falati, S., P. Gross, G. Merrill-Skoloff, B.C. Furie, and B.
Furie. 2002. Real-time in vivo imaging of platelets, tissue
factor and fibrin during arterial thrombus formation in the
mouse. Nat. Med. 8:1175–1181.
18. Rosen, E.D., S. Raymond, A. Zollman, F. Noria, M. Sando-
val-Cooper, A. Shulman, J.L. Merz, and F.J. Castellino.
2001. Laser-induced noninvasive vascular injury models in
mice generate platelet- and coagulation-dependent thrombi.
Am. J. Pathol. 158:1613–1622.
19. Ross, J.M., B.R. Alevriadou, and L.V. McIntire. 1998. Rhe-
ology. In Thrombosis and Hemorrhage. J.W. Pine, editor.
Williams & Wilkins, Baltimore, MD. 405–421.
20. Vial, C., and R.J. Evans. 2002. P2X(1) receptor-deficient
mice establish the native P2X receptor and a P2Y6-like re-
ceptor in arteries. Mol. Pharmacol. 62:1438–1445.
21. Kato, K., T. Kanaji, S. Russell, T.J. Kunicki, K. Furihata, S.
Kanaji, P. Marchese, A. Reininger, Z.M. Ruggeri, and J.
Ware. 2003. The contribution of glycoprotein VI to stable
platelet adhesion and thrombus formation illustrated by tar-
geted gene deletion. Blood. 10.1182/blood-2003-03-0717.
22. Hodivala-Dilke, K., K. McHugh, D. Tsakiris, H. Rayburn,
D. Crowley, M. Ullman-Cullere, F. Ross, B. Coller, S.
Teitelbaum, and R.O. Hynes. 1999. Beta3-integrin-deficient
mice are a model for Glanzmann thrombasthenia showing
placental defects and reduced survival. J. Clin. Invest. 103:
229–238.
23. Marcus, A., M. Broekman, J. Drosopoulos, D. Pinsky, N. Is-
lam, R. Gayle III, and C. Maliszewski. 2001. Thromboregu-
lation by endothelial cells: significance for occlusive vascular
diseases. Arterioscler. Thromb. Vasc. Biol. 21:178–182.
24. Enjyoji, K., J. Sevigny, Y. Lin, P.S. Frenette, P.D. Christie,
J.S. Esch II, M. Imai, J.M. Edelberg, H. Rayburn, M. Lech,
et al. 1999. Targeted disruption of cd39/ATP diphosphohy-
drolase results in disordered hemostasis and thromboregula-
tion. Nat. Med. 5:1010–1017.
25. Sage, S.O., E.H. Yamoah, and J.W. Heemskerk. 2000. The
roles of P(2X1)and P(2T AC)receptors in ADP-evoked cal-
cium signalling in human platelets. Cell Calcium. 28:119–126.
26. Vial, C., M.G. Rolf, M.P. Mahaut-Smith, and R.J. Evans.
2002. A study of P2X(1) receptor function in murine mega-
karyocytes and human platelets reveals synergy with P2Y re-
ceptors. Br. J. Pharmacol. 135:363–372.